New Filings & Updated Terms (ending 8.23.19am)

NEW FILINGS

Company: Ping Identity Holding Corp.
Symbol: PING
Description: Ping is pioneering Intelligent Identity. They enable secure access to any service, application or API from any device.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, BofA Merrill Lynch, RBC Capital, Citigroup, Barclays, Credit Suisse, Deutsche Bank, Wells Fargo
Co-Manager(s): Raymond James, Stifel, William Blair, Mizuho Securities, Oppenheimer
Filed: 8-23-19
Listed Cash Raise: $100m

Company: IGM Biosciences, Inc.
Symbol: IGMS
Description: They are a biotechnology company pioneering the development of engineered IgM antibodies for the treatment of cancer patients.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Piper Jaffray, Stifel, Guggenheim Securities
Filed: 8-19-19
Listed Cash Raise: $100m

Company: 10x Genomics, Inc.
Symbol: TXG
Description: They are a life science technology company building products to interrogate, understand and master biology.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Goldman Sachs, BofA Merrill Lynch
Co-manager(s): Cowen
Filed: 8-19-19
Listed Cash Raise: $100m

Company: Alerus Financial Corporation
Symbol: ALRS
Description: They are a diversified financial services company headquartered in Grand Forks, North Dakota.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Raymond James, DA Davidson
Co-Manager: Piper Jaffray
Filed: 8-16-19
Listed Cash Raise: $75m

Company: Satsuma Pharmaceuticals, Inc.
Symbol: STSA
Description: They are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Credit Suisse, SVB Leerink, Evercore ISI
Filed: 8-16-19
Listed Cash Raise: $86.25m

Company: SpringWorks Therapeutics, Inc.
Symbol: SWTX
Description: They are a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Goldman Sachs, Cowen
Co-Manager: Wedbush PacGrow
Filed: 8-16-19
Listed Cash Raise: $115m